Bristol Myers Squibb Co (BMY) financials

Bristol Myers Squibb Co (BMY) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, Bristol Myers Squibb Co reported revenue of $48.19B, down 0.2% year over year, net income of $7.05B, diluted EPS of $3.46 and free cash flow of $12.85B.

Revenue (fiscal 2025)

$48.19B

Revenue growth (fiscal 2025)

-0.2%

Net income (fiscal 2025)

$7.05B

Diluted EPS (fiscal 2025)

$3.46

Free cash flow (fiscal 2025)

$12.85B

Bristol Myers Squibb Co files with the U.S. Securities and Exchange Commission under CIK 0000014272, classified as Pharmaceutical Preparations.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.